✦ LIBER ✦

Magnetic resonance imaging and spectroscopic imaging: Improved patient selection and potential for metabolic intermediate endpoints in prostate cancer chemoprevention trials

✍ Scribed by John Kurhanewicz; Mark G Swanson; Penelope J Wood; Daniel B Vigneron

Book ID: 117263369
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 121 KB
Volume: 57
Category: Article
ISSN: 0090-4295
DOI: 10.1016/s0090-4295(00)00955-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PD19-09 COMPARISON OF THE PROSTATE CANCE

PD19-09 COMPARISON OF THE PROSTATE CANCER PREVENTION TRIAL (PCPT) RISK CALCULATOR AND MAGNETIC RESONANCE IMAGING IN SELECTING MEN FOR PROSTATE BIOPSIES

✍ Salami, Simpa; Fakhoury, Mathew; Ryniker, Laura; Yaskiv, Oksana; Turkbey, Baris; 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 122 KB

PROSTATE MRI AND MRSI (MAGNETIC RESONANC

PROSTATE MRI AND MRSI (MAGNETIC RESONANCE WITH SPECTROSCOPIC IMAGING) FOR DIAGNOSIS OF CAP (PROSTATE CANCER) IN PATIENTS WITH HIGH PSA LEVELS AND PREVIOUS NEGATIVE PROSTATE BIOPSY

✍ Anceschi, Umberto; Anceschi, Claudio; Gaffi, Marco; Regine, Giovanni; D'Amico, F 📂 Article 📅 2009 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 178 KB

Combination of Diffusion-weighted Magnet

Combination of Diffusion-weighted Magnetic Resonance Imaging and Extended Prostate Biopsy Predicts Lobes Without Significant Cancer: Application in Patient Selection for Hemiablative Focal Therapy

✍ Matsuoka, Yoh; Numao, Noboru; Saito, Kazutaka; Tanaka, Hiroshi; Kumagai, Jiro; Y 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 785 KB